Department of Chemical and Biological Sciences, Faculty of Science, Japan Women's University, Mejirodai 2-8-1, Bunkyoku, Tokyo 112-8681, Japan
Received on September 6, 2004; revised on October 26, 2004; accepted on October 27, 2004
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: epidermal secretion / GPI anchor / innate immunity / intelectin / N-glycosylation
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Several independent lines of study have recently identified molecules structurally similar to XCGL in ascidian plasma (Abe et al., 1999), Xenopus embryonic epidermis (Nagata et al., 2003
), mouse intestine (Komiya et al., 1998
), and several human tissues (Lee et al., 2001
; Suzuki et al., 2001
; Tsuji et al., 2001
). The DNA database also contains cDNA sequences encoding similar proteins in lamprey and Xenopus (Klein et al., 2002
; DDBJ accession numbers AB055981, AB01238, and AB01239). Precursor proteins of XCGL and these XCGL-like lectins have an N-terminal signal peptide for secretion. The mature lectins consist of N-glycosylated peptide subunits of
300330 amino acid residues that contain a highly conserved fibrinogen-like motif found in the Ficolin/Opsonin p35 that probably serves as a carbohydrate-recognition domain (Sugimoto et al., 1998
). They also have a rather divergent N-terminal and a relatively conserved C-terminal segments. Some of the lectins of this family are shown to be large oligomeric proteins of 120500 kDa in size consisting of 312 subunits linked by disulfide bonds (Chamow and Hedrick, 1986
; Suzuki et al., 2001
; Tsuji et al., 2001
). The lectins examined so far require Ca2+ for carbohydrate binding, but they do not have structural motifs characteristic to carbohydrate recognition domains of a class of Ca2+-dependent lectins, namely C-type lectins (Lee et al., 2001
; Nishihara et al., 1986
; Tsuji et al., 2001
; Yokosawa et al., 1982
). Thus XCGL and the XCGL-like molecules seem to fall into a unique group of lectins evolutionally conserved among chordates, designated the XCGL (Nagata et al., 2003
) or the eglectin family (Chang et al., 2004
).
Despite similarities of the XCGL-like lectins to XCGL in their molecular structures and carbohydrate-binding properties, little is known about their biological function. Human intelectin is thought to be a secretory protein that binds to a carbohydrate chain characteristic to the cell wall of certain class of bacteria, suggesting its role in antibacterial innate immunity of intestinal mucosa (Tsuji et al., 2001). However, the same protein has been isolated and characterized as a lactoferrin receptor, a glycosylphosphatidyl inositol (GPI)anchored iron transporterbinding protein on the membrane of the human intestinal brush border, suggesting a role in iron uptake from milk (Suzuki et al., 2001
). Furthermore, other researchers reported that the same human lectin, termed HL-1, is specifically expressed in the vascular endothelium and that a closely related lectin, HL-2, is expressed specifically in the intestine (Lee et al., 2001
). Although possible roles in innate immunity were suggested for lower vertebrate lectins found in the plasma or serum (Abe et al., 1999
), no substantial evidence to support this possibility has so far been available.
We have recently isolated a cDNA clone that encodes a novel XCGL family lectin, XEEL, expressed exclusively in the X. laevis embryonic epidermis (Nagata et al., 2003). To gain insights into roles of XEEL in embryonic development, we isolated XEEL from embryos and produced recombinant XEEL (rXEEL) to characterize its molecular nature and carbohydrate-binding properties. We also demonstrated that XEEL is produced by a major subset of embryonic epidermal cells and secreted into the environmental water in a developmentally regulated manner. To our knowledge, XEEL is the first XCGL family lectin secreted from the embryonic epidermis.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Structure and secretion of rXEEL
HEK-293T cells were transfected with the pCEP-XEEL vector, and the transient expression of the rXEEL protein was examined. Western blotting of the extract and the culture supernatant showed single protein bands at a molecular mass of 43 kDa, indicating production and secretion of the rXEEL by the transfected cells (Figure 2A). These bands were absent in the cell extract and the culture supernatant of control cells transfected with vacant pCEP4 vector. To purify the rXEEL protein, we established a cell line stably secreting rXEEL by hygromycin selection and applied the supernatants of the large-scale cultures to a galactose-Sepharose column. SDSPAGE analysis of the fractions eluted with TBS containing 10 mM EDTA resolved a major 260-kDa protein under nonreducing conditions (Figure 1B) and a single 43-kDa protein under reducing conditions (data not shown). These protein bands were recognized by the anti-XEEL monoclonal antibody 5G7 in western blotting (Figure 1B and 1C). Similar to XEEL isolated from embryos, rXEEL was reduced in protein size from 43 kDa to 37 kDa by N-glycosidase treatment (Figure 1C). Therefore, the basic structure of rXEEL protein seems identical to that of the XEEL protein isolated from embryos.
|
Next, we examined the effects of removal of N-linked carbohydrate on the carbohydrate-binding activity of rXEEL. The extracts were prepared from cells transiently expressing wild-type or mutant rXEEL proteins, incubated with galactose-Sepharose in the presence or absence of 10 mM CaCl2, and the bound proteins were examined by western blotting. Figure 2C demonstrates that the wild-type rXEEL and the mutant rXEEL(N183Q) bind similarly to galactose-Sepharose in the presence of Ca2+. The mutant rXEEL(N192Q) and rXEEL(N183Q/N192Q) also bind to galactose-Sepharose, although the relative amount of the bound proteins in the extracts is less than those of rXEEL and rXEEL(N183Q).
Carbohydrate-binding properties of XEEL and rXEEL
The purified XEEL and rXEEL were adsorbed onto galactose-Sepharose and eluted with TBS containing either EDTA or 100 mM of various saccharides in the presence of 10 mM CaCl2. The XEEL immunoreactivities in the eluates were detected by western blotting using 5G7 antibody and quantified by densitometry of the blots. XEEL bound to galactose-Sepharose was completely eluted by TBS containing 10 mM EDTA (Figure 3A). Pentoses released 70% (D-ribose) 95% (D-xylose) XEEL from galactose-Sepharose, whereas hexoses were less effective in releasing XEEL, with elutions of 5% (D-glucose) to 50% (D-fructose) of the galactose-bound XEEL (Figure 3B). Disaccharides (maltose, melibiose, and lactose) were completely ineffective in releasing the bound XEEL. These results indicate that among the saccharides used in the present study, pentoses have a higher affinity to XEEL than hexoses and disaccharides. rXEEL and rXEEL(N183Q) showed similar carbohydrate specificity profiles to XEEL, exhibiting a higher affinity to pentoses than to hexoses and disaccharides (Figure 3A, 3B; data for rXEEL(N183Q) not shown).
|
|
We have shown by in situ hybridization analyses that XEEL mRNA localizes in nonciliated epidermal cells of neurula and tailbud embryos (Nagata et al., 2003). To visualize distribution of the XEEL protein in embryos, tailbud embryos at stage 34 were whole-mount stained using the monoclonal antibody 5G7. Confocal fluorescence microscopy of the stained embryos demonstrated that the XEEL immunoreactivities were localized in a subset of epidermal cells and that no other internal tissues were immunolabeled. Strong immunoreactivities were found in patches in the perinuclear cytoplasm and irregular arrays of fine dots that may have been discernible as Golgi apparatus, cytoplasmic vesicles, and endoplasmic reticulum (Figure 5A). In the apical cytoplasm, the majority of the immunoreactivities were localized in round or oval granules of about 0.61.2 µm in diameter (Figure 5B). When embryos were incubated with either control mouse IgG or 5G7 antibody preabsorbed with rXEEL, no immunoreactivity was found in these structures of the epidermal cells (Figure 5C).
|
Extra-embryonic secretion of XEEL
To examine whether XEEL is secreted into the environmental water, we incubated the embryo-conditioned medium with galactose-Sepharose and examined the adsorbed proteins by western blotting using 5G7 antibody. Figure 6A shows accumulation of the XEEL protein in the conditioned medium during the cultivation of embryos for 6 h, demonstrating extra-embryonic secretion of XEEL. Next we cultured denuded or hatched embryos at various developmental stages in 1/10 Steinberg's solution for 3 h, and the embryo-conditioned media were analyzed by slot blotting. Figure 6B shows immunological detection of XEEL on the slot blot (inset) and developmental changes in the rate of embryonic XEEL secretion estimated by densitometry of the blot (histogram). XEEL secretion was undetectable or at low levels before hatching (stages 26 and 32) and then quickly increased to reach the highest level at stage 42, stayed at a high level during the first week after hatching (stages 3648), and declined to an undetectable level by the second week (stage 50). Similar results were obtained using double-distilled water for embryo culture.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The results of N-glycosidase digestion of XEEL and of analyses of the mutant rXEEL proteins suggest that XEEL is glycosylated at Asn-192, although the latter is based on the transfected cultured mammalian cell line. Substitution of Asn-192 of rXEEL to Gln caused a decrease of the apparent molecular size to that of deglycosylated XEEL, inhibition of its secretion, and accumulation in the cells. However, it did not abolish the carbohydrate-binding activity. The N-linked carbohydrate is, therefore, probably required for extracellular secretion of XEEL but is not an essential component of the carbohydrate recognition domain. It has been shown that N-glycosylation is critical (if not essential) for trafficking of certain proteins along the secretory pathways (Simizu et al., 2004). Alternative or additional roles of N-glycan may also be possible; for example, stabilization of XEEL after synthesis in embryonic cells and interaction with other proteins after secretion.
Figure 7A shows alignment of partial amino acid sequences of XCGL family lectins (Abe et al., 1999; Komiya et al., 1998
; Lee et al., 2001
; Mozingo and Hedrick, 1996
; Nagata et al., 2003
; Tsuji et al., 2001
; Suzuki et al., 2001
; DDBJ accession numbers AB055981, AB01238, and AB01239) containing conserved N-glycosylation motifs. The first sites (Asn-183 in XEEL) are conserved among all the lectins, whereas the second sites (Asn-192) are present in a limited group of lectins including XEEL. The first sites are always associated with a Pro residue C-terminal to Ser/Thr, which is in many cases known to prevent N-glycosylation (Gave and von Heijne, 1990
). Indeed, Asn-183 in rXEEL has a limited amount (if any at all) of linked carbohydrates with probably minor functional significance. Substitution of Asn-183 to Gln alone did not affect the apparent molecular size, carbohydrate-binding properties and secretion. However, both XCGL1 and XCGL2 have been shown to be nonglycosylated at the second sites but glycosylated at the first site (An et al., 2003
). Thus it may be worthwhile to see whether N-glycosylation at one of these sites is required for secretion of the other XCGL family lectins.
|
Figure 7B aligns C-terminal amino acid sequences of the XCGL family lectins, showing possible GPI anchor motifs that are determined by analyses of the amino acid sequences using DGPI version 2.04 software (DGPI Web site: http://dgpi.pathbot.com/). Unexpectedly, it predicts that XEEL and XCGL can be GPI-anchored to the plasma membrane at the C-terminus. In our preliminary study, embryonic epidermal cells or HEK-293T cells producing the wild-type or the mutant rXEEL were treated with phosphatidyl inositolspecific phospholipase C, and the liberated proteins were examined by western blotting. This study has failed to demonstrate GPI-anchored XEEL or rXEEL. These observations as well as the findings that XCGL and the human intelectin/transferrin receptor can take both GPI-anchored and secretory forms (Greve and Hedrick, 1978; Nomura et al., 1998
; Quill and Hedrick, 1994
; Roberson and Barondes, 1983
; Wyrick et al., 1974
) indicate that the destination of lectins is not determined by the presence of a GPI anchor motif alone. This in turn suggests that the choice of these lectins to take secretory or GPI-anchored forms depends on their posttranslational modification, including N-glycosylation in different cell types or even in a single cell.
It has long been known that the epidermis of various vertebrates produces and secretes lectins onto the body surface (Barondes, 1984; Tasumi et al., 2002
). In Xenopus, the adult epidermis produces and secretes into the lumen of skin glands a 16-kDa lactose-binding lectin of unknown function (Bols et al., 1986
; Marschal et al., 1992
). In addition, one of a family of ß-galactoside-binding lectins, Xgalectin VIIa has been found in unfertilized eggs, embryos, larvae, and some adult tissues (Shoji et al., 2002
, 2003
). This lectin is
34 kDa in size and abundant in embryonic and larval epidermis, although its secretion has not been confirmed. Other Xenopus tissues also produce several groups of lectins, including galactosidebinding lectins produced by adult liver (Roberson et al., 1985
) or embryonic tissues (Frunchak et al., 1993
; Harris and Zalik, 1985
; Milos et al., 1998
). All these lectins obviously differ from XEEL in protein size and structure, carbohydrate-binding properties, tissue distribution, patterns of developmental expression, and/or secretion. Although a gene encoding a possible ortholog of XEEL has been found in the Xenopus tropicalis genome (Klein et al., 2002
), no information is available on the protein. Thus, to our knowledge, XEEL is the first XCGL family lectin that has been demonstrated in embryonic epidermal secretion.
The overall carbohydrate-binding properties of XEEL, including Ca2+ dependence and affinity profiles to various saccharides, are quite similar to those of human intelectin (Tsuji et al., 2001). Both XEEL and human intelectin exhibit high affinity to pentoses (D-arabinose, D-ribose, D-xylose), moderate affinity to hexoses (D-fructose, D-galactose, D-glucose, D-mannose), and undetectable affinity to disaccharides (lactose, maltose, melibiose) in similar competitive assays using galactose-Sepharose. Human intelectin has been shown to recognize galactofuranosyl residues of carbohydrates present in the cell walls of certain bacteria (Tsuji et al., 2001
). It has also been reported that recombinant mouse intelectin produced by Escherichia coli has a toxic activity in the bacteria (Komiya et al., 1998
). Based on these results, we estimated that mammalian intelectins act as antimicrobial effecter molecules in the innate immune system of intestinal mucosa (Tsuji et al., 2001
). XEEL may also participate in a similar antimicrobial activity in the secretion of the outer (epidermal) surface of the body, instead of the inner (intestinal) surface.
Patterns of changes in the XEEL content of the embryo and the rate of extra-embryonic secretion indicate that XEEL production and secretion are developmentally regulated. Onset of XEEL gene expression occurs zygotically at early gastrula stages (Nagata et al., 2003), and the protein appears in the epidermis of early tailbud embryos. The secretion starts at around the hatching stage and stays at high levels during the first week after hatching (stages 3648), followed by a decline to an undetectable level at stage 50. Acquired immunity in Xenopus, as judged by antibody production and allograft rejection, is not demonstrable before 2 weeks after fertilization (stage 49) (Du Pasquier et al., 1996
). In addition, various antimicrobial peptides in skin secretions have so far been identified only in adult and late larval stages of X. laevis (Kreil, 1996
). Combining these facts and the above-mentioned possible antimicrobial activity, we presume that XEEL may play a role to protect free-living embryos and early larvae from pathogenic microorganisms in the environmental water, although the antimicrobial activity of XEEL remains to be demonstrated.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Purification of XEEL
The galactose-Sepharose affinity gel was prepared by incubation of epoxy-activated Sepharose 6B (Pharmacia Biotech, Uppsala, Sweden) with D-galactose according to the manufacturer's instructions. Two to three thousand hatched embryos at stages 3537 were homogenized in 10 ml TBS (20 mM TrisHCl buffer [pH 7.5] containing 150 mM NaCl), supplemented with 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 5 mM iodoacetamide by passing them several times through a 20-gauge needle attached to a syringe barrel. The homogenate was centrifuged at 500 x g for 5 min at 4°C. The supernatant was transferred to a new tube and centrifuged again at 11,000 x g for 30 min. The pellet was washed twice by homogenization in 20 ml TBS, centrifuged at 11,000 x g for 30 min, and resuspended in 10 ml TBS containing 1 mM phenylmethylsulfonyl fluoride, 5 mM iodoacetamide, and 10 mM 3-[(3-chloramidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) (Sigma, St. Louis, MO). The suspension was kept overnight at 4°C with continuous rocking. It was then centrifuged at 11,000 x g for 30 min, supplemented with CaCl2 to a final concentration of 10 mM, and mixed with 3 ml of the galactose-Sepharose matrix. The mixture was incubated for 3 h at room temperature with continuous rocking.
The gel in the mixture was washed twice in buffer and loaded onto a small plastic column with a diameter of 1 cm. The column was washed with 20 ml TBS containing 10 mM CHAPS and 10 mM CaCl2 at a flow rate of 0.3 ml/min, and the galactose-binding proteins were eluted with TBS containing 10 mM CaCl2 and 20 mM D-xylose. The eluate was collected as 0.2-ml fractions, and XEEL was detected by western blotting. On some occasions, the fractions containing XEEL were pooled, dialyzed in TBS, and concentrated by centrifugation in a Centricut Mini tube (Biofield, Tokyo) before storing at 80°C.
Production and analyses of rXEEL
The cDNA fragment encoding the whole coding region of XEEL was amplified by polymerase chain reaction (PCR) using XEEL cDNA (Nagata et al., 2003) as a template. The amplified product was cloned into the pCEP4 plasmid vector (Invitrogen, Carlsbad, CA) to create pCEP-XEEL. The plasmid DNA was purified using a QIAGEN column (QIAGEN, Tokyo) and used to transfect human epithelial kidney cell line HEK-293T. The cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 µg/ml streptomycin sulfate, and 100 U/ml penicillin in a CO2 incubator. The cells were plated in 3 ml medium at 5 x 105 cells per well of six-well plates (Corning, Corning, NY) and transfected 24 h later with the plasmid DNA by the calcium phosphate method (Sambrook and Russel, 2001
). The medium was changed the next day, and the cells and the culture supernatants were harvested 48 h later to examine transient expression and secretion of the recombinant protein.
To establish cell lines producing the recombinant protein, we selected transfected cells by cultivation in medium containing 100 µg/ml hygromycin B (Sigma). To purify rXEEL from the large-scale culture, we harvested the culture supernatant by centrifugation at 10,500 x g for 20 min; supplemented it with iodoacetamide (5 mM at a final concentration), CHAPS (10 mM), and CaCl2 (10 mM); and loaded it onto the galactose-Sepharose column as described previously. After washing, rXEEL was eluted with TBS containing 10 mM EDTA and detected by western blotting. The fractions containing the rXEEL were pooled, dialyzed in TBS, and concentrated by centrifugation in a Centricut Mini tube.
XEEL has two putative N-glycosylation sites at Asn-183 and Asn-192 (consensus, Asn-Xaa-Ser/Thr where Xaa is not Pro). We generated mutant cDNAs encoding rXEEL with amino acid substitution of one or both of the Asn residues to Gln residues by PCR-mediated, site-directed mutagenesis using the overlap extension technique (Ho et al., 1989). The sequences of antisense mutagenesis primers with nucleotide substitutions (underscored) are 5'-GTGTTTTCTGGGGCACATGC-3', 5'-GATGACTGCCTCCACATAAC-3', and 5'-GACTGCCTCCACATAACCATTGGTGTTTTCTGGGGCAC-3'. The mutant cDNAs were amplified using KOD-Plus-DNA polymerase (Toyobo, Tokyo). The sequences were confirmed, and the restriction fragments containing the mutated site were introduced into pCEP-XEEL to create pCEP-XEEL(N183Q), pCEP-XEEL(N192Q), and pCEP-XEEL(N183Q/N192Q), respectively. The cDNA encoding heat-stable human alkaline phosphatase was excised from APtag-4 vector (GenHunter, Nashville, TN) and inserted into the pCEP4 vector to create pCEP-AP. HEK-293T cells were transfected with the vectors, and the cells and the culture supernatants were harvested 2 days after transfection to examine properties of mutant rXEEL proteins. Alkaline phosphatase activities in extracts and culture supernatants of the transfected cells were assayed using AP Activity Assay Reagent A (GenHunter) according to the manufacturer's instructions.
Monoclonal antibodies
To obtain antibodies to XEEL, we produced a bacterial rXEEL peptide and used it as an antigen. The peptide (amino acid 43 to 142 of the conceptual translate of the cDNA clone) contains the XEEL-specific segment and a part of the fibrinogen-like motif that is highly conserved in the XCGL family (Nagata et al., 2003). A fragment of the XEEL cDNA encoding the peptide was amplified by PCR and cloned into the pET32c plasmid (Novagen, Madison, WI). BL21 strain E. coli bacteria were transformed with the recombinant vector, and production of the recombinant fusion protein with a thioredoxin tag was induced with 1 mM ispropylthiogalactoside (Ambion, Austin, TX). Soluble bacterial extracts were fractionated by SDSPAGE, and the recombinant protein was isolated from the gel using an Electroeluter apparatus (Bio-Rad Laboratories, Hercules, CA). Balb/c mice were immunized with the purified recombinant fusion protein, and two hybridoma clones secreting IgG1(
) antibodies, 3E4 and 5G7, were established by standard procedures (Harlow and Lane, 1988
). The hybridoma cells were injected intraperitoneally into Balb/c mice, and the ascites containing high titer monoclonal antibody was harvested and stored at 80°C. A monoclonal antibody to chicken gizzard actin was purchased from Chemicon (Temecula, CA).
Western and slot blotting
Freshly dissected adult tissues were homogenized in 19 volumes of SDS-sample buffer (62.5 mM Tris-HCl, 2.3% SDS, 5% ß-mercaptoethanol, 10% glycerol, pH 6.8) using a Polytron homogenizer (Kinematica, Littau, Switzerland). Embryos and cultured cells were homogenized in buffer at 50 embryos/ml or 5 x 106 cells/ml. The homogenates were centrifuged at 11,000 x g for 10 min, and the supernatant was used as samples. Embryo conditioned media was concentrated to 0.5 ml by centrifugation in Centricut Mini tubes, mixed with 25 µl 20x concentrated TBS and 5 µl 1 M CaCl2, and incubated for 1 h at room temperature with 50 µl 50% galactose-Sepharose suspension in TBS. The cultured cells were homogenized in SDS-sample buffer at 2 x 106 cells/ml, and the culture supernatant was mixed with the same volume of 2x SDS sample buffer.
Alkaline phosphatase activities in extracts and culture supernatants of the transfected cells were assayed using AP Activity Assay Reagent A (GenHunter) according to the manufacturer's instructions. The affinity beads were washed in TBS containing 10 mM CaCl2, and the bound proteins were extracted with 30 µl SDSPAGE sample buffer. Proteins in the sample were heat denatured for 3 min at 100°C, fractionated by SDSPAGE, and transferred to a polyvinylidene difluoride membrane. The embryo-conditioned medium was slot blotted onto a nitrocellulose membrane using a Bio-Dot apparatus (Bio-Rad) according to the manufacturer's instructions. The membranes were blocked with 5% skim milk in TBS-T and incubated sequentially with a mouse monoclonal antibody and an anti-mouse IgG goat antibody conjugated with horseradish peroxidase (Biosource, Camarillo, CA). The blots were developed with ECL-Plus western blot detection reagent (Amersham Biosciences, Tokyo), and the chemiluminescent signals were captured and analyzed with a VersaDoc 5000 image analysis system and Quantity One software (Bio-Rad).
N-glycosidase treatment
The purified XEEL or rXEEL fractions containing 50 ng protein were dissolved in 20 µl 200 mM TrisHCl buffer (pH 8.0) containing 0.1% SDS, 50 mM ß-mercaptoethanol, and 50 mM EDTA and denatured at 100°C for 5 min. The denatured samples were mixed with the same volume of 2.5% Nonidet P-40 and incubated with 1 µl of either 0.5 U of N-glycosidase (Boehringer, Mannheim, Germany) or TBS at 37°C for 16 h. The treated samples were analyzed by western blotting using an anti-XEEL monoclonal antibody 5G7.
Saccharide-binding assay
To examine activities of XEEL or rXEEL to bind various saccharides, we mixed aliquots of 200 µl of the purified samples containing 10 mM CaCl2 with 20 µl galactose-Sepharose and incubated for 1 h at room temperature with continuous shaking. The gels were washed four times with TBS containing 10 mM CaCl2 and then resuspended in TBS containing either 10 mM EDTA or 10 mM CaCl2 plus 100 mM of one of the following saccharides: pentoses D-arabinose, D-ribose, D-xylose; hexoses D-fructose, D-galactose, D-glucose, D-mannose; or disaccharides lactose, maltose, melibiose. After the mixtures were agitated for 10 min at room temperature, they were centrifuged, and the supernatants were subjected to western blotting.
Immunofluorescence staining and immuno-electron microscopy
For immunofluorescence staining, tailbud embryos at stage 34 were fixed overnight with 4% paraformaldehyde in phosphate buffered saline, bleached, and permeabilized with 10% H2O2 and 5% dimethyl sulfoxide in methanol for 23 days. The embryos were washed in phosphate buffered saline, blocked in 1% normal goat sera, and then incubated sequentially with monoclonal anti-XEEL antibody 5G7 (diluted 1:2000) and tetramethylrhodamine isothiocyanatelabeled anti-mouse IgG goat antibody (Biosource). The embryos were whole mounted, or the epidermis was peeled off of the stained embryo under the dissecting microscope and then mounted on a glass slide. The preparations were observed and the images were captured with a confocal laser beam microscope (Leica Microsystems, Wetzlar, Germany).
For immuno-electron microscopy, embryos were fixed in 0.1 M Na-cacodylate buffer containing 0.5% glutaraldehyde and 4% paraformaldehyde for 2 h and embedded in LR White (London Resin, Reading, U.K.). Thin sections were successively incubated with 5G7 monoclonal antibody and anti-mouse IgG-colloidal gold conjugates (Aurion, Wageningen, Netherlands), followed by treatment with a silver enhancement kit (Aurion). Immunolabeled sections were examined and photographed with an electron microscope JEM1200 EXS (JEOL, Tokyo).
![]() |
Acknowledgements |
---|
![]() |
Abbreviations |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
An, H.J., Peavy, T.R., Hedrick, J.L., and Lebrilla, C.B. (2003) Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal. Biochem., 75, 56285637.
Barondes, S.H. (1984) Soluble lectins: a new class of extracellular protein. Science, 223, 12591264.[ISI][Medline]
Bols, N.C., Roberson, M.M., Haywood-Reid, P.L., Cerra, R.F., and Barondes, S.H. (1986) Secretion of a cytoplasmic lectin from Xenopus laevis skin. J. Cell Biol., 102, 492499.[Abstract]
Chamow, S.M. and Hedrick, J.L. (1986) Subunit structure of a cortical granule lectin involved in the block to polyspermy in Xenopus laevis eggs. FEBS Lett., 206, 353357.[CrossRef][ISI][Medline]
Chang, B.Y., Peavy, T.R., Wardrip, N.J., and Hedrick, J.L. (2004) The Xenopus laevis cortical granule lectin: cDNA cloning, developmental expression, and identification of the eglectin family of lectins. Comp. Biochem. Physiol. A, 137, 115129.[CrossRef][ISI]
Dodd, R.B. and Drickamer, K. (2001) Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity. Glycobiology, 11, 7179.[CrossRef]
Du Pasquier, L., Wilson, M., and Robert, J. (1996) The immune system of Xenopus: with special references to B cell development and immunoglobulin genes. In Tinsley, R.C. and Kobel, H.R. (Eds.), The biology of Xenopus. Clarendon Press, Oxford, pp. 301313.
Frunchak, Y.N., Martha, G.N., McFadden, K.D., and Milos, N.C. (1993) Alteration of heart development in Xenopus laevis by galactoside-binding lectin or its sugar hapten inhibitor. Anat. Embryol., 187, 299316.[ISI][Medline]
Fujita, T. (2002) Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol., 2, 346353.[ISI][Medline]
Gave, I.Y. and von Heijne, G. (1990) Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng., 3, 433442.[ISI][Medline]
Greve, L.C. and Hedrick, J.L. (1978) An immunocytochemical localization of the cortical granule lectin in fertilized and unfertilized egg of Xenopus laevis. Gamete Res., 1, 1318.[ISI]
Harlow, E. and Lane, D. (1988) Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Harris, H. and Zalik, S.E. (1985) Studies on the endogenous galactose-binding lectin during early development of the embryo of Xenopus laevis. J. Cell Sci., 79, 105117.[Abstract]
Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R. (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene, 77, 5159.[CrossRef][ISI][Medline]
Klein, S.L., Strausberg, R.L., Wagner, L., Pontius, J., Clifton, S.W., and Richardson, P. (2002) Genetic and genomic tools for Xenopus research: the NIH Xenopus initiative. Dev. Dyn., 225, 384391.[CrossRef][ISI][Medline]
Komiya, T., Tanigawa, Y., and Hirohashi, S. (1998) Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem. Biophys. Res. Commun., 251, 759762.[CrossRef][ISI][Medline]
Kreil, G. (1996) Skin secretions of Xenopus laevis. In Tinsley, R.C. and Kobel, H.R. (Eds.), The biology of Xenopus. Clarendon Press, Oxford, pp. 263277.
Lee, J.K., Buckhaults, P., Wilkes, C., Teilhet, M., King, M.L., Moremen, K.W., and Pierce, M. (1997) Cloning and expression of a Xenopus laevis oocyte lectin and characterization of its mRNA levels during early development. Glycobiology, 7, 363373.
Lee, J.K., Schnee, J., Pang, M., Wolfert, M., Baum, L.G., Moremen, K.W., and Pierce, M. (2001) Human homologues of Xenopus oocyte cortical granule lectin XL35. Glycobiology, 11, 6373.
Marschal, P., Herrmann, J., Leffler, H., and Cooper, D.N. (1992) Sequence and specificity of a soluble lactose-binding lectin from Xenopus laevis skin. J. Biol. Chem., 267, 1294212849.
Milos, N.C., Meadows, G., Evanson, J.E., Pinchbeck, J.B., Bawa, N., Young, K.J., Palmer, N.G., Murdoch, C.A., and Carmel, D. (1998) Expression of the endogenous galactose-binding lectin of Xenopus laevis during cranial neural crest development: lectin localization is similar to that of members of the N-CAM and cadherin families of the adhesion molecules. J. Craniofac. Genet. Dev. Biol., 18, 1129.[ISI][Medline]
Mozingo, N. and Hedrick, J.L. (1996) Localization of the cortical granule lectin ligand in Xenopus laevis eggs. Dev. Growth Differ., 38, 647652.[CrossRef][ISI]
Nagata, S., Nakanishi, M., Nanba, R., and Fujita, N. (2003) Developmental expression of XEEL, a novel molecule of the Xenopus oocyte cortical granule lectin family. Dev. Genes Evol. 213, 368370.[CrossRef][ISI][Medline]
Nieuwkoop, P.D. and Faber, J. (1994) Normal table of Xenopus laevis (Daudin). Garland, New York.
Nishihara, T., Wyrick, R.E., Working, P.K., Chen, Y.H., and Hedrick, J.L. (1986) Isolation and characterization of a lectin from the cortical granules of Xenopus laevis egg. Biochemistry, 25, 60136020.[ISI][Medline]
Nomura, K.H., Kobayashi, R., Hirabayashi, Y., Fujise-Sakai, M., Mizuguchi, S., and Nomura, K. (1998) Involvement of blood-group-B-active trisaccharides in Ca2+-dependent cellcell adhesion in the Xenopus blastula. Dev. Genes Evol., 208, 918.[CrossRef][ISI][Medline]
Outenreath, R.L., Roberson, M.M., and Barondes, S.H. (1988) Endogenous lectin secretion into the extracellular matrix of early embryos of Xenopus laevis. Dev. Biol., 125, 187194.[ISI][Medline]
Peng, H.B. (1991) Xenopus laevis: practical uses in cell and molecular biology. Solutions and protocols. Meth. Cell Biol., 36, 657662.[Medline]
Quill, T.A. and Hedrick, J.L. (1994) Oviductal localization of the cortical granule lectin ligand involved in the block to polyspermy in Xenopus laevis. Dev. Growth Differ., 36, 615620.[ISI]
Quill, T.A. and Hedrick, J.L. (1996) The fertilization layer mediated block to polyspermy in Xenopus laevis: isolation of the cortical granule lectin ligand. Arch. Biochem. Biophys., 333, 326332.[CrossRef][ISI][Medline]
Roberson, M.M. and Barondes, S.H. (1982) Lectin from embryos and oocytes of Xenopus laevis: purifications and properties. J. Biol. Chem., 257, 75207524.
Roberson, M.M. and Barondes, S.H. (1983) Xenopus laevis lectin is localized at several sites in oocytes, eggs and embryos. J. Cell. Biol., 97, 18751881.[Abstract]
Roberson, M.M., Wolffe, A.P., Tata, J.R., and Barondes, S.H. (1985) Galactoside-binding serum lectin of Xenopus laevis. Estrogen-dependent hepatocyte synthesis and relationship to oocyte lectin. J. Biol. Chem., 260, 1102711032.
Sambrook, J. and Russel, D.W. (2001) Molecular cloning: a laboraory manual, 3rd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
Schrag, J.D., Procopio, D.O., Cygler, M., Thomas, D.Y., and Bergeron, J.J. (2003) Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem. Sci., 28, 4957.[CrossRef][ISI][Medline]
Shoji, H., Nishi, N., Hirashima, M., and Nakamura, T. (2002) Purification and cDNA cloning of Xenopus liver galectins and their expression. Glycobiology, 12, 163172.
Shoji, H., Nishi, N., Hirashima, M., and Nakamura, T. (2003) Characterization of the Xenopus galectin family. Three structurally different types as in mammals and regulated expression during embryogenesis. J. Biol. Chem., 278, 1228512293.
Simizu, S., Ishida, K., Wierzba, M.K., and Osada, H. (2004) Secretion of heparanase protein is regulated by glycosylation in human tumor cell lines. J. Biol. Chem., 279, 26972703.
Sugimoto, R., Yae, Y., Akaiwa, M., Kitajima, S., Shibata, Y., Sato, H., Hirata, J., Okochi, K., Izuhara, K., and Hamasaki, N. (1998) Cloning and characterization of the Hakata antigen, a member of the Ficolin/Opsoninp35 lectin family. J. Biol. Chem., 273, 2072120727.
Suzuki, Y.A., Shin, K., and Lönnerdal, B. (2001) Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry, 40, 1577115779.[CrossRef][ISI][Medline]
Tasumi, S., Ohira, T., Kawazoe, I., Suetake, H., Suzuki, Y., and Aida, K. (2002) Primary structure and characteristics of a lectin from skin mucus of the Japanese eel Anguilla japonica. J. Biol. Chem., 277, 2730527311.
Tsuji, S., Uehori, J., Matsumoto, M., Suzuki, Y., Matsuhisa, A., Toyoshima, K., and Seya, T. (2001) Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem., 276, 2345623463.
Wyrick, R.E., Nishihara, T., and Hedrick, J.L. (1974) Agglutination of jelly coat and cortical granule components and the block of polyspermy in the amphibian Xenopus laevis. Proc. Natl Acad. Sci. USA, 71, 20672071.[Abstract]
Yokosawa, H., Sawada, H., Abe, Y., Numakunai, T., and Ishii, S. (1982) Galactose-specific lectin in the hemolymph of solitary ascidian, Halocynthia roretzi: isolation and characterization. Biochem. Biophys. Res. Comm., 107, 451457.[ISI][Medline]
|